Coston McIsaac & Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
10
﹤0.01% 914
2025
Q4
$0 Hold
10
﹤0.01% 908
2025
Q3
$0 Hold
10
﹤0.01% 857
2025
Q2
$0 Buy
+10
New +$72 ﹤0.01% 831
2025
Q1
Sell
-10
Closed 834
2024
Q4
$0 Hold
10
﹤0.01% 832
2024
Q3
$0 Hold
10
﹤0.01% 816
2024
Q2
$0 Hold
10
﹤0.01% 799
2024
Q1
$0 Hold
10
﹤0.01% 780
2023
Q4
$0 Hold
10
﹤0.01% 778
2023
Q3
$0 Buy
+10
New +$233 ﹤0.01% 794

Other funds holding TDOC

Coston McIsaac & Partners's TDOC Position: Q1 2026 in Review

Coston McIsaac & Partners held its Teladoc Health (TDOC) position steady in Q1 2026 at 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Coston McIsaac & Partners first reported a position in TDOC in Q3 2023 and has held it in 10 quarters since. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Coston McIsaac & Partners held 10 shares of Teladoc Health worth $0 as of Q1 2026.
  • Coston McIsaac & Partners left its Teladoc Health share count unchanged in Q1 2026.
  • Teladoc Health made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q1 2026, its #914 holding.
  • Coston McIsaac & Partners first reported a position in Teladoc Health in Q3 2023 and has held it in 10 quarters since.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.